CRISPR Therapeutics AG (CRSP)
56.19
+0.52
(+0.93%)
USD |
NASDAQ |
May 17, 16:00
55.91
-0.28
(-0.50%)
After-Hours: 20:00
CRISPR Therapeutics 1 Year Total Returns (Daily): -9.77% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -9.77% |
May 15, 2024 | -13.63% |
May 14, 2024 | -12.82% |
May 13, 2024 | -12.91% |
May 10, 2024 | -24.49% |
May 09, 2024 | -15.56% |
May 08, 2024 | -4.77% |
May 07, 2024 | -0.47% |
May 06, 2024 | 2.28% |
May 03, 2024 | 13.62% |
May 02, 2024 | 14.61% |
May 01, 2024 | 9.64% |
April 30, 2024 | 8.28% |
April 29, 2024 | 12.04% |
April 26, 2024 | 10.81% |
April 25, 2024 | 8.70% |
April 24, 2024 | 8.95% |
April 23, 2024 | 8.46% |
April 22, 2024 | 7.02% |
April 19, 2024 | 2.94% |
April 18, 2024 | 8.17% |
April 17, 2024 | 2.34% |
April 16, 2024 | 15.21% |
April 15, 2024 | 16.72% |
April 12, 2024 | 39.57% |
Date | Value |
---|---|
April 11, 2024 | 38.54% |
April 10, 2024 | 36.93% |
April 09, 2024 | 43.59% |
April 08, 2024 | 41.17% |
April 05, 2024 | 40.40% |
April 04, 2024 | 48.84% |
April 03, 2024 | 42.67% |
April 02, 2024 | 43.78% |
April 01, 2024 | 50.74% |
March 28, 2024 | 55.44% |
March 27, 2024 | 58.20% |
March 26, 2024 | 63.41% |
March 25, 2024 | 63.67% |
March 22, 2024 | 64.47% |
March 21, 2024 | 65.34% |
March 20, 2024 | 64.06% |
March 19, 2024 | 57.32% |
March 18, 2024 | 56.25% |
March 15, 2024 | 62.40% |
March 14, 2024 | 59.49% |
March 13, 2024 | 63.56% |
March 12, 2024 | 74.22% |
March 11, 2024 | 77.74% |
March 08, 2024 | 64.66% |
March 07, 2024 | 65.91% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-68.03%
Minimum
Jan 24 2022
287.7%
Maximum
Mar 16 2021
24.24%
Average
6.40%
Median
1 Year Total Returns (Daily) Benchmarks
Vertex Pharmaceuticals Inc | 27.67% |
Novartis AG | 3.66% |
Intellia Therapeutics Inc | -40.11% |
Regeneron Pharmaceuticals Inc | 30.41% |
Viking Therapeutics Inc | 180.2% |